EUCTR2009-015649-21-NO进行中（未招募）不适用
Immunmodulating and clinical effect of vitamin D onthe induction of remission in the patients with moderate to severe ulcerative colitis under the treatment with Infliximab.
Medical clinic, University Hospital of North Norway0 个研究点目标入组 200 人开始时间: 2009年9月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •males and females 18-75 years old with active ulcerative colitis
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Known diabetes, coronary infarction or stroke in the last 12 months, cancer diagnoses the last 5 years, renal stone last 15 months, solarium more than once weekly, planning more than 4 weeks in a tropical country the enxt 6 months, pregnant or lactating women, women of fertile age without safe pregnancy prevention (birth control pill, IUD). Those using psycopharmaca or vitamin D on prescription, those taking vitamin D supplementation more than 400 IU per day. nut allergy, serum creatinine levels above 130 umol/l for males and > 110 umol/l for females. subjects with primary hyperparathyroidism, subjects with sarcoidosis.
研究者
相似试验
进行中（未招募）
1 期
The Immunomodulatory Role of Vitamin D in Inflammatory Bowel Disease (IBDVit): IBDVit1 - Trial of Adjuvant Vitamin D with Corticosteroids in Active Crohn’s Disease; IBDVit2 - Trial of Adjuvant Vitamin D with Infliximab in Active Crohn's Disease; IBDVit3 - Trial of Adjuvant Vitamin D with standard maintenance therapy in preventing relapse of Inflammatory Bowel Disease. - IBDVitIBDVit1 - Active Crohn's Disease IBDVit2 - Active Crohn's Disease IBDVit3 - Crohn's Disease in remission / Ulcerative Colitis in remissionMedDRA version: 9.1 Level: LLT Classification code 10011401 Term: Crohn's diseaseMedDRA version: 9.1 Level: LLT Classification code 10045365 Term: Ulcerative colitisEUCTR2007-006692-37-GBImperial College London210
已完成
不适用
Effect of Vitamin D supplementation in treatment of First episode PsychosisCTRI/2017/07/009136Central Institute of Psychiatry60
进行中（未招募）
1 期
Hepatitis immunisation and vitamin D supplementatioThe effect of vitamin D supplementation on immune response following hepatitis B vaccine in incident and prevalent hemodialysis patients with vitamin D deficiencyMedDRA version: 14.1Level: LLTClassification code 10054181Term: Hepatitis B immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10019480Term: HemodialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-004621-26-ATMedical University Graz
已完成
2 期
Clinical and laboratory Efects of vitamin D supplementation in adolescent with polycystic ovarian syndrome and vitamin D deficiencyAdolescent with polycystic ovarian syndrome and vitamin D deficiency.Polycystic ovarian syndromeOvarian dysfunction, unspecifiedE28.2E2IRCT2016021125732N2Vice Chancellor for Research, Semnan University of Medical sciences50
进行中（未招募）
1 期
An initial, short-duration study of vitamin D versus an inactive therapy on the ability of the human immune system to counteract the effects of Multiple Sclerosis on the brain and the effects of vitamin D on the immune system in healthy individuals.MedDRA version: 14.1Level: HLTClassification code 10052785Term: Multiple sclerosis acute and progressiveSystem Organ Class: 10029205 - Nervous system disordersMultiple SclerosisEUCTR2012-000635-68-IEniversity College Dublin